No association of xenotropic murine leukemia virus-related viruses with prostate cancer

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Switzer, William M ^a   Jia, Hongwei ^a   Zheng, Hao Qiang ^a   Tang, Shaohua ^a   Heneine, Walid ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; POL PROTEIN; RIBONUCLEASE L; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS RNA; 2 5A DEPENDENT RIBONUCLEASE; 2-5A-DEPENDENT RIBONUCLEASE; MITOCHONDRIAL DNA; RIBONUCLEASE;

ADULT; AGED; ALLELE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LATENT VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; POLYTROPIC MULV RELATED VIRUS; PREVALENCE; PROSTATE CANCER; PROTEIN EXPRESSION; RETROVIRUS; RNA SEQUENCE; SEROLOGY; VIRAL TROPISM; VIREMIA; VIRUS CARCINOGENESIS; VIRUS RECOMBINATION; WESTERN BLOTTING; XENOTROPIC MULV RELATED VIRUS; GENETICS; METABOLISM; MIDDLE AGED; PATHOGENICITY; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; VIROLOGY;

MURINE LEUKEMIA VIRUS; XENOTROPIC MURINE LEUKEMIA VIRUS;

ADULT; AGED; BLOTTING, WESTERN; DNA, MITOCHONDRIAL; ENDORIBONUCLEASES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

EID: 79955760880     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019065     Document Type: Article

References (40)

1. Moorthy HK, Venugopal P, (2008) Strategies for prostate cancer prevention: Review of the literature. Indian J Urol 24: 295-302.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
3. Odedina FT, Akinremi TO, Chinegwundoh F, Roberts R, Yu D, et al. (2009) Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer 4 (Suppl 1): S2.
4. Mo Z, Gao Y, Cao Y, Gao F, Jian L, (2009) An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review. Prostate 69: 662-688.
5. Murad A, Lewis SJ, Smith GD, Collin SM, Chen L, et al. (2009) PTGS2-899G>C and prostate cancer risk: a population-based nested case-control study (ProtecT) and a systematic review with meta-analysis. Prostate Cancer Prostatic Dis.
6. Silverman RH, (2003) Implications for RNase L in prostate cancer biology. Biochemistry 42: 1805-1812.
7. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, et al. (2006) Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2: e25.
8. Morse HC, (2007) Retroelements in the Mouse. In: Fox JG, Barthold S, Davisson M, Newcomer CE, Quimby FW, Smith A, editors. The Mouse in Biomedical Research 2nd ed St. Louis, MO Elsevier, Inc pp. 269-279.
9. Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR, (2009) XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proceedings of the National Academy of Sciences of the United States of America 106: 16351-16356.
10. Danielson BX, Ayala GX, Kimata JX, (2010) Detection of Xenotropic Murine Leukemia Virus-Related Virus in Normal and Tumor Tissue of Patients from the Southern United States with Prostate Cancer Is Dependent on Specific Polymerase Chain Reaction Conditions. J Infect Dis.
11. Arnold RS, Makarova NV, Osunkoya AO, Suppiah S, Scott TA, et al. (2010) XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology 75: 755-761.
12. Verhaegh GW, de Jong AS, Smit FP, Jannink SA, Melchers WJ, et al. (2010) Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in dutch prostate cancer patients. Prostate.
13. Aloia AL, Sfanos KS, Isaacs WB, Zheng Q, Maldarelli F, et al. (2010) XMRV: A New Virus in Prostate Cancer? Cancer Res.
14. Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, et al. (2009) Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology 6.
15. Sfanos KS, Sauvageot J, Fedor HL, Dick JD, De Marzo AM, et al. (2008) A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate 68: 306-320.
16. Fischer N, Hellwinkel O, Schulz C, Chun FK, Huland H, et al. (2008) Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol 43: 277-283.
17. Erlwein O, Kaye S, McClure MO, Weber J, Wills G, et al. (2010) Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One 5: e8519.
18. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, et al. (2009) Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326: 585-589.
19. Groom HC, Boucherit VC, Makinson K, Randal E, Baptista S, et al. (2010) Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology 7: 10.
20. van Kuppeveld FJ, Jong AS, Lanke KH, Verhaegh GW, Melchers WJ, et al. (2010) Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ 340: c1018.
21. Switzer WM, Jia H, Hohn O, Zheng H, Tang S, et al. (2010) Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology.
22. Hong P, Li J, Li Y, (2010) Failure to detect Xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome. Virol J 7: 224.
23. Henrich TX, Li JX, Felsenstein D, Kotton CX, Plenge RX, et al. (2010) Xenotropic Murine Leukemia Virus-Related Virus Prevalence in Patients with Chronic Fatigue Syndrome or Chronic Immunomodulatory Conditions. J Infect Dis.
24. Lo SC, Pripuzova N, Li B, Komaroff AL, Hung GC, et al. (2010) Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci U S A 107: 15874-15879.
25. Hue S, Gray ER, Gall A, Katzourakis A, Tan CP, et al. (2010) Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 7: 111.
26. Robinson MJ, Erlwein OW, Kaye S, Weber J, Cingoz O, et al. (2010) Mouse DNA contamination in human tissue tested for XMRV. Retrovirology 7: 108.
27. Lerche NW, Cotterman RF, Dobson MD, Yee JL, Rosenthal AN, et al. (1997) Screening for simian type-D retrovirus infection in macaques, using nested polymerase chain reaction. Lab Anim Sci 47: 263-268.
28. Qiu X, Swanson P, Luk KC, Tu B, Villinger F, et al. (2010) Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies. Retrovirology 7: 68.
29. Sharma P, Suppiah S, Molinaro RJ, Rogers K, Das Gupta J, et al. (2010) Organ and Cell Lineage Dissemination of XMRV in Rhesus macaques during Acute and Chronic Infection. Conference on Retroviruses and Opportunistic Infections. San Francisco, CA.
30. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, et al. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419.
31. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, et al. (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348: 255-256.
32. Knouf EC, Metzger MJ, Mitchell PS, Arroyo JD, Chevillet JR, et al. (2009) Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells. J Virol 83: 7353-7356.
33. Garson JA, Kellam P, Towers GJ, (2011) Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection. Retrovirology 8: 13.
34. Kim S, Kim N, Dong B, Boren D, Lee SA, et al. (2008) Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. J Virol 82: 9964-9977.
35. Wolfe ND, Switzer WM, Carr JK, Bhullar VB, Shanmugam V, et al. (2004) Naturally acquired simian retrovirus infections in central African hunters. Lancet 363: 932-937.
36. Busch MP, Switzer WM, Murphy EL, Thomson R, Heneine W, (2000) Absence of evidence of infection with divergent primate T-lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test results. Transfusion 40: 443-449.
37. Tamura K, Dudley J, Nei M, Kumar S, (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
38. Guindon S, Lethiec F, Duroux P, Gascuel O, (2005) PHYML Online-a web server for fast maximum likelihood-based phylogenetic inference. Nucleic Acids Res 33: W557-559.
39. Hussain AI, Shanmugam V, Bhullar VB, Beer BE, Vallet D, et al. (2003) Screening for simian foamy virus infection by using a combined antigen Western blot assay: evidence for a wide distribution among Old World primates and identification of four new divergent viruses. Virology 309: 248-257.
40. Matthews AL, Brown J, Switzer W, Folks TM, Heneine W, et al. (1999) Development and validation of a Western immunoblot assay for detection of antibodies to porcine endogenous retrovirus. Transplantation 67: 939-943.